Nike's risky new ad campaign featuring NFL player Colin Kaepernick has paid off in higher sales and increased attention from analysts who have raised ratings and price targets and said lots of…
Apple, IBM, Merck, and Travelers buoyed the Dow index on Thursday.
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Apple held on to its position as the best performing Dow stock for the year to date last week. Next Wednesday the company will introduce new iPhones and other products to the…
Boeing, Visa, Merck, and Verizon posted large enough gains to keep the Dow in the green Thursday.
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Nike stock added more than 3% to its share price last week, leading the company to wrestle away from Apple the position as the best performing Dow stock of 2018.
The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm and Target.
Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch.
Nike, Johnson & Johnson, Merck, and Home Depot were Monday's leading gainers.
After an absence of more than a year, Apple is once more the top-performing Dow stock for the year to date. Considering the company's market cap of $1.05 trillion, that's quite an…
The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors. Here we identify some of the top health care picks.
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Merck reported better-than-expected second-quarter results before the markets opened on Friday, but shares retreated afterward.
Chris Lange The July 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
